Search Page

1

Cite

Share

WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth.

Thomson CS, Pundavela J, Perrino MR, Coover RA, Choi K, Chaney KE, Rizvi TA, Largaespada DA, Ratner N. Thomson CS, et al. Oncogene. 2021 Jun;40(24):4229-4241. doi: 10.1038/s41388-021-01773-x. Epub 2021 Jun 2. Oncogene. 2021. PMID: 34079083 Free PMC article.

Cite

Share

2

Cite

Share

COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm.

Campbell C, Sommerfield T, Clark GRC, Porteous L, Milne AM, Millar R, Syme T, Thomson CS. Campbell C, et al. Among authors: thomson cs. Prev Med. 2021 Oct;151:106606. doi: 10.1016/j.ypmed.2021.106606. Epub 2021 Jun 30. Prev Med. 2021. PMID: 34217418 Free PMC article.

Cite

Share

3

Cite

Share

The challenge of using routinely collected data to compare hospital admission rates by ethnic group: a demonstration project in Scotland.

Knox S, Bhopal RS, Thomson CS, Millard A, Fraser A, Gruer L, Buchanan D. Knox S, et al. Among authors: thomson cs. J Public Health (Oxf). 2020 Nov 23;42(4):748-755. doi: 10.1093/pubmed/fdz175. J Public Health (Oxf). 2020. PMID: 31884514 Free article.

Cite

Share

4

Cite

Share

Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1.

Coover RA, Healy TE, Guo L, Chaney KE, Hennigan RF, Thomson CS, Aschbacher-Smith LE, Jankowski MP, Ratner N. Coover RA, et al. Among authors: thomson cs. Acta Neuropathol Commun. 2018 Nov 23;6(1):127. doi: 10.1186/s40478-018-0635-9. Acta Neuropathol Commun. 2018. PMID: 30470263 Free PMC article.

Cite

Share

5

Cite

Share

A summary of the updated report on the incidence and epidemiological trends of keratinocyte cancers in the UK 2013-2018.

Kwiatkowska M, Ahmed S, Ardern-Jones MR, Bhatti LA, Bleiker TO, Gavin A, Hussain S, Huws DW, Irvine L, Langan SM, Millington GWM, Mitchell H, Murphy R, Paley L, Proby CM, Thomson CS, Thomas R, Turner C, Vernon S, Venables ZC. Kwiatkowska M, et al. Among authors: thomson cs. Br J Dermatol. 2022 Feb;186(2):367-369. doi: 10.1111/bjd.20764. Epub 2021 Nov 24. Br J Dermatol. 2022. PMID: 34564854 No abstract available.

Cite

Share

6

Cite

Share

Mortality related to novel psychoactive substances in Scotland, 2012: an exploratory study.

McAuley A, Hecht G, Barnsdale L, Thomson CS, Graham L, Priyadarshi S, Robertson JR. McAuley A, et al. Among authors: thomson cs. Int J Drug Policy. 2015 May;26(5):461-7. doi: 10.1016/j.drugpo.2014.10.010. Epub 2014 Nov 10. Int J Drug Policy. 2015. PMID: 25477285

Cite

Share

7

Cite

Share

Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010.

Brewster DH, Lang J, Bhatti LA, Thomson CS, Oien KA. Brewster DH, et al. Among authors: thomson cs. Cancer Epidemiol. 2014 Jun;38(3):227-34. doi: 10.1016/j.canep.2014.03.010. Epub 2014 Apr 13. Cancer Epidemiol. 2014. PMID: 24726751

Cite

Share

8

Cite

Share

What is the lifetime risk of developing cancer?: the effect of adjusting for multiple primaries.

Sasieni PD, Shelton J, Ormiston-Smith N, Thomson CS, Silcocks PB. Sasieni PD, et al. Among authors: thomson cs. Br J Cancer. 2011 Jul 26;105(3):460-5. doi: 10.1038/bjc.2011.250. Epub 2011 Jul 19. Br J Cancer. 2011. PMID: 21772332 Free PMC article.

Cite

Share

9

Cite

Share

The risk of oesophageal cancer is not affected by a diagnosis of breast cancer.

Cooper SC, Croft S, Day R, Thomson CS, Trudgill NJ. Cooper SC, et al. Among authors: thomson cs. Eur J Cancer Prev. 2010 May;19(3):182-5. doi: 10.1097/CEJ.0b013e3283372137. Eur J Cancer Prev. 2010. PMID: 20145541

Cite

Share

10

Cite

Share

Second primary malignancies after treatment for malignant lymphoma.

Okines A, Thomson CS, Radstone CR, Horsman JM, Hancock BW. Okines A, et al. Among authors: thomson cs. Br J Cancer. 2005 Aug 22;93(4):418-24. doi: 10.1038/sj.bjc.6602731. Br J Cancer. 2005. PMID: 16106249 Free PMC article.

Cite

Share